Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 367

1.

Should all patients with HL who relapse after ASCT be considered for allogeneic SCT? A consult, yes; a transplant, not necessarily.

Moskowitz CH.

Blood Adv. 2018 Apr 10;2(7):821-824. doi: 10.1182/bloodadvances.2017011130. No abstract available.

2.

The Neutrino Puzzle.

Moskowitz C.

Sci Am. 2017 Sep 19;317(4):32-39. doi: 10.1038/scientificamerican1017-32. No abstract available.

PMID:
29565869
3.

Radiographic Predictors of Resectability in Thymic Carcinoma.

Hayes SA, Huang J, Golia Pernicka J, Cunningham J, Zheng J, Moskowitz CS, Ginsberg MS.

Ann Thorac Surg. 2018 Mar 10. pii: S0003-4975(18)30331-X. doi: 10.1016/j.athoracsur.2018.02.019. [Epub ahead of print]

PMID:
29534953
4.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N.

J Natl Compr Canc Netw. 2018 Mar;16(3):245-254. doi: 10.6004/jnccn.2018.0013.

PMID:
29523663
5.

Transplant strategies in relapsed/refractory Hodgkin lymphoma.

Shah GL, Moskowitz CH.

Blood. 2018 Apr 12;131(15):1689-1697. doi: 10.1182/blood-2017-09-772673. Epub 2018 Mar 2. Review.

PMID:
29500170
6.

Role of Radiation Therapy in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group.

Ng AK, Yahalom J, Goda JS, Constine LS, Pinnix CC, Kelsey CR, Hoppe B, Oguchi M, Suh CO, Wirth A, Qi S, Davies A, Moskowitz CH, Laskar S, Li Y, Mauch PM, Specht L, Illidge T.

Int J Radiat Oncol Biol Phys. 2018 Mar 1;100(3):652-669. doi: 10.1016/j.ijrobp.2017.12.005. Review.

PMID:
29413279
7.

A phase 1 study of ibrutinib in combination with R-ICE in patients with relapsed or primary refractory DLBCL.

Sauter CS, Matasar MJ, Schoder H, Devlin SM, Drullinsky P, Gerecitano J, Kumar A, Noy A, Palomba ML, Portlock CS, Straus DJ, Zelenetz AD, McCall SJ, Miller ST, Courtien AI, Younes A, Moskowitz CH.

Blood. 2018 Apr 19;131(16):1805-1808. doi: 10.1182/blood-2017-08-802561. Epub 2018 Jan 31.

PMID:
29386196
8.

Porpoise-Driven Life.

Moskowitz C.

Sci Am. 2018 Jan 16;318(2):15-17. doi: 10.1038/scientificamerican0218-15b. No abstract available.

PMID:
29337933
9.

Arms Down Cone Beam CT Hepatic Angiography Performance Assessment: Vascular Imaging Quality and Imaging Artifacts.

Gonzalez-Aguirre AJ, Petre EN, Hsu M, Moskowitz CS, Solomon SB, Durack JC.

Cardiovasc Intervent Radiol. 2018 Jan 11. doi: 10.1007/s00270-017-1875-y. [Epub ahead of print]

PMID:
29327076
10.

Using Free-Response Receiver Operating Characteristic Curves to Assess the Accuracy of Machine Diagnosis of Cancer.

Moskowitz CS.

JAMA. 2017 Dec 12;318(22):2250-2251. doi: 10.1001/jama.2017.18686. No abstract available.

PMID:
29234793
11.

Interim results of brentuximab vedotin in combination with nivolumab in patients with relapsed or refractory Hodgkin lymphoma.

Herrera AF, Moskowitz AJ, Bartlett NL, Vose JM, Ramchandren R, Feldman TA, LaCasce AS, Ansell SM, Moskowitz CH, Fenton K, Ogden CA, Taft D, Zhang Q, Kato K, Campbell M, Advani RH.

Blood. 2018 Mar 15;131(11):1183-1194. doi: 10.1182/blood-2017-10-811224. Epub 2017 Dec 11.

PMID:
29229594
12.

Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.

Giulino-Roth L, O'Donohue T, Chen Z, Trippett TM, Klein E, Kernan NA, Kobos R, Prockop SE, Scaradavou A, Shukla N, Steinherz PG, Moskowitz AJ, Moskowitz CH, Boulad F.

Leuk Lymphoma. 2017 Nov 29:1-10. doi: 10.1080/10428194.2017.1403601. [Epub ahead of print]

PMID:
29183202
13.

Comparison of screening CEDM and MRI for women at increased risk for breast cancer: A pilot study.

Jochelson MS, Pinker K, Dershaw DD, Hughes M, Gibbons GF, Rahbar K, Robson ME, Mangino DA, Goldman D, Moskowitz CS, Morris EA, Sung JS.

Eur J Radiol. 2017 Dec;97:37-43. doi: 10.1016/j.ejrad.2017.10.001. Epub 2017 Oct 7.

PMID:
29153365
14.

Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.

Morton LM, Sampson JN, Armstrong GT, Chen TH, Hudson MM, Karlins E, Dagnall CL, Li SA, Wilson CL, Srivastava DK, Liu W, Kang G, Oeffinger KC, Henderson TO, Moskowitz CS, Gibson TM, Merino DM, Wong JR, Hammond S, Neglia JP, Turcotte LM, Miller J, Bowen L, Wheeler WA, Leisenring WM, Whitton JA, Burdette L, Chung C, Hicks BD, Jones K, Machiela MJ, Vogt A, Wang Z, Yeager M, Neale G, Lear M, Strong LC, Yasui Y, Stovall M, Weathers RE, Smith SA, Howell R, Davies SM, Radloff GA, Onel K, Berrington de González A, Inskip PD, Rajaraman P, Fraumeni JF Jr, Bhatia S, Chanock SJ, Tucker MA, Robison LL.

J Natl Cancer Inst. 2017 Nov 1;109(11). doi: 10.1093/jnci/djx058.

PMID:
29059430
15.

Highlights in Lymphoma From the 2017 ASCO Meeting and the 14th ICML: Commentary.

Moskowitz CH.

Clin Adv Hematol Oncol. 2017 Sep;15 Suppl 11(9):21-23. No abstract available.

PMID:
29036042
16.

Prognostic utility of differential tissue characterization of cardiac neoplasm and thrombus via late gadolinium enhancement cardiovascular magnetic resonance among patients with advanced systemic cancer.

Chan AT, Plodkowski AJ, Pun SC, Lakhman Y, Halpenny DF, Kim J, Goldburg SR, Matasar MJ, Moskowitz CS, Gupta D, Steingart R, Weinsaft JW.

J Cardiovasc Magn Reson. 2017 Oct 12;19(1):76. doi: 10.1186/s12968-017-0390-2.

17.

Making a measurable difference in advanced Huntington disease care.

Moskowitz CB, Rao AK.

Handb Clin Neurol. 2017;144:183-196. doi: 10.1016/B978-0-12-801893-4.00016-X. Review.

PMID:
28947117
18.

Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma.

Moskowitz AJ, Schöder H, Gavane S, Thoren KL, Fleisher M, Yahalom J, McCall SJ, Cadzin BR, Fox SY, Gerecitano J, Grewal R, Hamlin PA, Horwitz SM, Kumar A, Matasar M, Ni A, Noy A, Palomba ML, Perales MA, Portlock CS, Sauter C, Straus D, Younes A, Zelenetz AD, Moskowitz CH.

Blood. 2017 Nov 16;130(20):2196-2203. doi: 10.1182/blood-2017-06-788877. Epub 2017 Sep 5.

PMID:
28874350
19.

Radiation-associated breast cancer and gonadal hormone exposure: a report from the Childhood Cancer Survivor Study.

Moskowitz CS, Chou JF, Sklar CA, Barnea D, Ronckers CM, Friedman DN, Neglia JP, Turcotte L, Howell RM, Henderson TO, Armstrong GT, Leisenring WM, Robison LL, van Leeuwen FE, Pike MC, Oeffinger KC.

Br J Cancer. 2017 Jul 11;117(2):290-299. doi: 10.1038/bjc.2017.169. Epub 2017 Jun 20.

PMID:
28632729
20.

Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.

Grommes C, Pastore A, Palaskas N, Tang SS, Campos C, Schartz D, Codega P, Nichol D, Clark O, Hsieh WY, Rohle D, Rosenblum M, Viale A, Tabar VS, Brennan CW, Gavrilovic IT, Kaley TJ, Nolan CP, Omuro A, Pentsova E, Thomas AA, Tsyvkin E, Noy A, Palomba ML, Hamlin P, Sauter CS, Moskowitz CH, Wolfe J, Dogan A, Won M, Glass J, Peak S, Lallana EC, Hatzoglou V, Reiner AS, Gutin PH, Huse JT, Panageas KS, Graeber TG, Schultz N, DeAngelis LM, Mellinghoff IK.

Cancer Discov. 2017 Sep;7(9):1018-1029. doi: 10.1158/2159-8290.CD-17-0613. Epub 2017 Jun 15.

PMID:
28619981
21.

Safety and tolerability of pembrolizumab in patients with relapsed/refractory primary mediastinal large B-cell lymphoma.

Zinzani PL, Ribrag V, Moskowitz CH, Michot JM, Kuruvilla J, Balakumaran A, Zhang Y, Chlosta S, Shipp MA, Armand P.

Blood. 2017 Jul 20;130(3):267-270. doi: 10.1182/blood-2016-12-758383. Epub 2017 May 10.

PMID:
28490569
22.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, Benitez CM, Bernat K, Bierman PJ, Blum KA, Chen R, Dabaja B, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maloney DG, Mauch PM, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Poppe M, Rabinovitch R, Seropian S, Smith M, Winter JN, Yahalom J, Burns J, Ogba N, Sundar H.

J Natl Compr Canc Netw. 2017 May;15(5):608-638.

PMID:
28476741
23.

Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

Thomas AA, Abrey LE, Terziev R, Raizer J, Martinez NL, Forsyth P, Paleologos N, Matasar M, Sauter CS, Moskowitz C, Nimer SD, DeAngelis LM, Kaley T, Grimm S, Louis DN, Cairncross JG, Panageas KS, Briggs S, Faivre G, Mohile NA, Mehta J, Jonsson P, Chakravarty D, Gao J, Schultz N, Brennan CW, Huse JT, Omuro A.

Neuro Oncol. 2017 Oct 1;19(10):1380-1390. doi: 10.1093/neuonc/nox086.

PMID:
28472509
24.

Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma.

Chen R, Zinzani PL, Fanale MA, Armand P, Johnson NA, Brice P, Radford J, Ribrag V, Molin D, Vassilakopoulos TP, Tomita A, von Tresckow B, Shipp MA, Zhang Y, Ricart AD, Balakumaran A, Moskowitz CH; KEYNOTE-087.

J Clin Oncol. 2017 Jul 1;35(19):2125-2132. doi: 10.1200/JCO.2016.72.1316. Epub 2017 Apr 25.

25.

Morbidity and mortality after treatment of Ewing sarcoma: A single-institution experience.

Friedman DN, Chastain K, Chou JF, Moskowitz CS, Adsuar R, Wexler LH, Chou AJ, DeRosa A, Candela J, Magnan H, Pun S, Kahan T, Wolden SL, Meyers PA, Oeffinger KC.

Pediatr Blood Cancer. 2017 Nov;64(11). doi: 10.1002/pbc.26562. Epub 2017 Apr 18.

PMID:
28417551
26.

Morbidity and Mortality Associated With Meningioma After Cranial Radiotherapy: A Report From the Childhood Cancer Survivor Study.

Bowers DC, Moskowitz CS, Chou JF, Mazewski CM, Neglia JP, Armstrong GT, Leisenring WM, Robison LL, Oeffinger KC.

J Clin Oncol. 2017 May 10;35(14):1570-1576. doi: 10.1200/JCO.2016.70.1896. Epub 2017 Mar 24.

PMID:
28339329
27.

Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.

Rimner A, Lovie S, Hsu M, Chelius M, Zhang Z, Chau K, Moskowitz AJ, Matasar M, Moskowitz CH, Yahalom J.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):1066-1076. doi: 10.1016/j.ijrobp.2017.01.222. Epub 2017 Feb 1.

28.

Risk factors and a prognostic score for survival after autologous stem-cell transplantation for relapsed or refractory Hodgkin lymphoma.

Bröckelmann PJ, Müller H, Casasnovas O, Hutchings M, von Tresckow B, Jürgens M, McCall SJ, Morschhauser F, Fuchs M, Borchmann P, Moskowitz CH, Engert A.

Ann Oncol. 2017 Jun 1;28(6):1352-1358. doi: 10.1093/annonc/mdx072.

PMID:
28327958
29.

Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma.

Gopal AK, Fanale MA, Moskowitz CH, Shustov AR, Mitra S, Ye W, Younes A, Moskowitz AJ.

Ann Oncol. 2017 May 1;28(5):1057-1063. doi: 10.1093/annonc/mdx028.

PMID:
28327905
30.

The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma.

Soumerai JD, Zelenetz AD, Moskowitz CH, Palomba ML, Hamlin PA Jr, Noy A, Straus DJ, Moskowitz AJ, Younes A, Matasar MJ, Horwitz SM, Portlock CS, Konner JA, Gounder MM, Hyman DM, Voss MH, Fury MG, Gajria D, Carvajal RD, Ho AL, Beumer JH, Kiesel B, Zhang Z, Chen A, Little RF, Jarjies C, Dang TO, France F, Mishra N, Gerecitano JF.

Clin Cancer Res. 2017 Aug 1;23(15):4119-4126. doi: 10.1158/1078-0432.CCR-16-3068. Epub 2017 Mar 17.

31.

Recommended.

Moskowitz C.

Sci Am. 2017 Mar 14;316(4):76. doi: 10.1038/scientificamerican0417-76. No abstract available.

PMID:
28296832
32.

Recommended.

Moskowitz C.

Sci Am. 2017 Feb 14;316(3):76. doi: 10.1038/scientificamerican0317-76. No abstract available.

PMID:
28207710
33.

A case report of concurrent embryonal rhabdomyosarcoma and diffuse large B-cell lymphoma in an adult without identifiable cancer predisposition.

Mathias MD, Ortiz MV, Magnan H, Ambati SR, Slotkin EK, Chou AJ, Walsh MF, Offit K, Moskowitz C, Kentsis A, Wexler LH.

Biomark Res. 2017 Feb 8;5:7. doi: 10.1186/s40364-017-0086-7. eCollection 2017.

34.

Recommended.

Moskowitz C.

Sci Am. 2017 Jan 17;316(2):72. doi: 10.1038/scientificamerican0217-72. No abstract available.

PMID:
28118348
35.

Differentiation of Clear Cell Renal Cell Carcinoma From Other Renal Cortical Tumors by Use of a Quantitative Multiparametric MRI Approach.

Hötker AM, Mazaheri Y, Wibmer A, Karlo CA, Zheng J, Moskowitz CS, Tickoo SK, Russo P, Hricak H, Akin O.

AJR Am J Roentgenol. 2017 Mar;208(3):W85-W91. doi: 10.2214/AJR.16.16652. Epub 2017 Jan 17.

36.

Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.

Friedman DN, Hilden P, Moskowitz CS, Suzuki M, Boulad F, Kernan NA, Wolden SL, Oeffinger KC, Sklar CA.

Biol Blood Marrow Transplant. 2017 Mar;23(3):475-482. doi: 10.1016/j.bbmt.2016.12.623. Epub 2016 Dec 28.

37.

Screening for thyroid cancer in survivors of childhood and young adult cancer treated with neck radiation.

Tonorezos ES, Barnea D, Moskowitz CS, Chou JF, Sklar CA, Elkin EB, Wong RJ, Li D, Tuttle RM, Korenstein D, Wolden SL, Oeffinger KC.

J Cancer Surviv. 2017 Jun;11(3):302-308. doi: 10.1007/s11764-016-0588-6. Epub 2016 Dec 27.

PMID:
28028762
38.

Recommended.

Moskowitz C.

Sci Am. 2016 Dec 20;316(1):68. doi: 10.1038/scientificamerican0117-68. No abstract available.

PMID:
28004719
39.

Tangled Up in Spacetime.

Moskowitz C.

Sci Am. 2016 Dec 20;316(1):32-37. doi: 10.1038/scientificamerican0117-32. No abstract available.

PMID:
28004705
40.

Outcomes of primary refractory diffuse large B-cell lymphoma (DLBCL) treated with salvage chemotherapy and intention to transplant in the rituximab era.

Vardhana SA, Sauter CS, Matasar MJ, Zelenetz AD, Galasso N, Woo KM, Zhang Z, Moskowitz CH.

Br J Haematol. 2017 Feb;176(4):591-599. doi: 10.1111/bjh.14453. Epub 2016 Dec 16.

41.

Catheter-directed endovascular application of thrombin: Report of 3 cases and review of the literature.

Maybody M, Madoff DC, Thornton RH, Morales SA, Moskowitz CS, Hsu M, Brody LA, Brown KT, Covey AM.

Clin Imaging. 2017 Mar - Apr;42:96-105. doi: 10.1016/j.clinimag.2016.11.018. Epub 2016 Nov 29.

42.

Recommended.

Moskowitz C.

Sci Am. 2016 Aug 16;315(3):86. doi: 10.1038/scientificamerican0916-86. No abstract available.

PMID:
27924890
43.

Differentiation of Uterine Leiomyosarcoma from Atypical Leiomyoma: Diagnostic Accuracy of Qualitative MR Imaging Features and Feasibility of Texture Analysis.

Lakhman Y, Veeraraghavan H, Chaim J, Feier D, Goldman DA, Moskowitz CS, Nougaret S, Sosa RE, Vargas HA, Soslow RA, Abu-Rustum NR, Hricak H, Sala E.

Eur Radiol. 2017 Jul;27(7):2903-2915. doi: 10.1007/s00330-016-4623-9. Epub 2016 Dec 5.

PMID:
27921159
44.

Recommended.

Moskowitz C, Sheikh K.

Sci Am. 2016 Oct 18;315(5):76. doi: 10.1038/scientificamerican1116-76. No abstract available.

PMID:
27918505
45.

Novel agents and strategies in transplant-eligible patients with relapsed and refractory Hodgkin lymphoma.

Moskowitz C.

Hematology Am Soc Hematol Educ Program. 2016 Dec 2;2016(1):331-338. Review.

PMID:
27913499
46.

Role of Positron Emission Tomography in Diffuse Large B-cell Lymphoma.

Shah GL, Moskowitz CH.

Hematol Oncol Clin North Am. 2016 Dec;30(6):1215-1228. doi: 10.1016/j.hoc.2016.07.003. Review.

PMID:
27888876
47.

Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.

Shah GL, Yahalom J, Matasar MJ, Verwys SL, Goldman DA, Bantilan KS, Zhang Z, McCall SJ, Moskowitz AJ, Moskowitz CH.

Br J Haematol. 2016 Nov;175(3):440-447. doi: 10.1111/bjh.14245. Epub 2016 Jul 5.

48.

Computed Tomographic Appearance of Organizing Pneumonia in an Oncologic Patient Population.

Long NM, Plodkowski AJ, Schor-Bardach R, Geyer AI, Zheng J, Moskowitz CS, Ginsberg MS.

J Comput Assist Tomogr. 2017 May/Jun;41(3):437-441. doi: 10.1097/RCT.0000000000000520.

PMID:
27768620
49.

A Comprehensive Assessment of Toxicities in Patients with Central Nervous System Lymphoma Undergoing Autologous Stem Cell Transplantation Using Thiotepa, Busulfan, and Cyclophosphamide Conditioning.

Scordo M, Bhatt V, Hsu M, Omuro AM, Matasar MJ, DeAngelis LM, Dahi PB, Moskowitz CH, Giralt SA, Sauter CS.

Biol Blood Marrow Transplant. 2017 Jan;23(1):38-43. doi: 10.1016/j.bbmt.2016.09.024. Epub 2016 Oct 3.

50.

Consolidation therapy after autologous stem cell transplant in relapsed/refractory Hodgkin lymphoma.

Moskowitz CH.

Clin Adv Hematol Oncol. 2016 Sep;14(9):662-4. No abstract available.

PMID:
27673283

Supplemental Content

Loading ...
Support Center